Korean Drug Co Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

View full details License your company rating Get 100s of ESG datapoints for Korean Drug Co Ltd

Detailed ESG analysis of Korean Drug Co Ltd are reached by logging in. The analysis of Korean Drug Co Ltd was prepared by All Street Sevva using leading NLP. If you are employed by Korean Drug Co Ltd and you wish to licence your ESG rating, please get in touch.

Korean Drug Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.3; made up of an environmental score of 3.2, social score of 2.7 and governance score of 1.1.

1/10 free views/searches used

You're viewing a Free Open ESG Rating.
To access the most comprehensive ESG data experience, Sign up to SEVVA Platform.

SDG Transparency Score for Korean Drug Co Ltd ⓘ

2.3

Low Impact

0 - 3

Medium

4 - 6

High

7 - 10

Last Score Update: 2023-01-01

What drives the score for Korean Drug Co Ltd ⓘ

3.2

Environmental

2.7

Social

1.1

Governance

SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

Rank	Company	SDG Transparency Score ⓘ	Performance
1	Novartis AG	9.6	High
2	Eli Lilly and Co	9.5	High
	...	...	...
2274	XBiotech Inc	2.4	Medium
2274	XOMA Corp	2.4	Medium
2297	Korean Drug Co Ltd	2.3	Medium
2297	Active Fine Chemicals Ltd	2.3	Medium
2297	American Vietnamese Biotech Inc	2.3	Medium
	...	...	...
2824	Wilson Therapeutics AB	0.0	Low
2824	Zyden Gentec Ltd	0.0	Low
	...	...	...

View the full peer group of 3274 companies on the SEVVA platformSign up for free

SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Korean Drug Co Ltd reference operational or capital allocation in relation to climate change?No

No answer found for the question

Is Capital Expenditure linked to emissions reduction?

Subscription required

Does the Board describe its role in the oversight of climate-related risks and opportunities?No

No answer found for the question

Has Korean Drug Co Ltd submitted or committed to submit to a shareholder vote (say-on-climate) its climate strategy?

Subscription required

Does Korean Drug Co Ltd disclose current and historical air emissions?

Does Korean Drug Co Ltd disclose current and / or historical ozone-depleting emissions?

Does Korean Drug Co Ltd disclose current and / or historical scope 1 emissions?

Does Korean Drug Co Ltd disclose current and / or historical scope 2 emissions?

Does Korean Drug Co Ltd disclose current and / or historical scope 3 emissions?

Subscription required

Does Korean Drug Co Ltd disclose current and / or historical emissions broken down by scope?

Subscription required

Does Korean Drug Co Ltd disclose GHG and Air Emissions intensity?

Does Korean Drug Co Ltd disclose GHG Targets?

Does Korean Drug Co Ltd disclose data for NOx, SOx and VOCs emissions?

Does Korean Drug Co Ltd disclose its Scope Emissions targets?

Subscription required

Does Korean Drug Co Ltd disclose current and historical energy intensity?

Does Korean Drug Co Ltd disclose its current and / or historical energy use?

Does Korean Drug Co Ltd disclose energy use targets?

Does Korean Drug Co Ltd disclose its Renewable Energy targets?

Subscription required

Recommend delete

Does Korean Drug Co Ltd disclose its biodiversity policy?

Does Korean Drug Co Ltd disclose its forestry policy?

Does Korean Drug Co Ltd disclose its internal carbon price?

Subscription required

Does Korean Drug Co Ltd disclose long-term targets (>5 years) for reducing its GHG emissions?

Does Korean Drug Co Ltd disclose Scope 3 emissions from use of sold products?

Subscription required

Does Korean Drug Co Ltd disclose current and historical material use?

Are Operating Expesnses linked to emissions reduction?

Does Korean Drug Co Ltd disclose climate scenario or pathway analysis?

Does Korean Drug Co Ltd reflect climate-related risks in its financial statements?

Does Korean Drug Co Ltd disclose the number and percentage of companies screened by environmental and social criteria?

Subscription required

Are emissions metrics verified by CDP?

Subscription required

Are emissions metrics verified by STBi?

Subscription required

Does Korean Drug Co Ltd report according to TCFD requirements?

Does Korean Drug Co Ltd disclose current and historical waste generation?

Does Korean Drug Co Ltd disclose current and / or historical waste management?

Subscription required

Does Korean Drug Co Ltd disclose waste targets?

Subscription required

Has Korean Drug Co Ltd published clear targets on waste management?

Does Korean Drug Co Ltd disclose current and / or historical water consumption?

Subscription required

Does Korean Drug Co Ltd disclose its waste policy?

Does Korean Drug Co Ltd disclose water use targets?

Does Korean Drug Co Ltd condunt supply chain audits?

Does Korean Drug Co Ltd engage third parties to conduct supply chain audit?

Does Korean Drug Co Ltd disclose board meeting attendance?

Are there worker representatives on the board?

Does Korean Drug Co Ltd disclose long term financial targets?

Subscription required

Does Korean Drug Co Ltd report NPS (customer loyalty, customer churn or satisfaction surveys) ?

Does Korean Drug Co Ltd report customer churn rates?

Subscription required

Does Korean Drug Co Ltd have a policy relating to cyber security?

Does Korean Drug Co Ltd disclose cybersecurity risks?

Does Korean Drug Co Ltd adhere to ISO 27001 / ISO 27002 standards or the NIST cybersecurity framework?

Subscription required

Does Korean Drug Co Ltd conduct cybersecurity training?

Subscription required

Does Korean Drug Co Ltd disclose the individual responsible for D&I?

Does Korean Drug Co Ltd conduct 360 degree staff reviews?

Does Korean Drug Co Ltd have engagement surveys, a culture survey, a pulse survey?

Does Korean Drug Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

Does Korean Drug Co Ltd disclose the vesting percentage required for performance threshold in the LTIP?

Subscription required

Has Korean Drug Co Ltd issued a profit warning in the past 24 months?

Does Korean Drug Co Ltd report the average age of the workforce?

Does Korean Drug Co Ltd report internal employee trust metrics such as ENPS?

Does Korean Drug Co Ltd permit its workforce to engage in collective bargaining?

Does Korean Drug Co Ltd disclose average employee tenure?

Subscription required

Does Korean Drug Co Ltd refer to human capital or people risk in its risk disclosures?

Subscription required

Does Korean Drug Co Ltd promote decent work conditions in relation to its supply chain?

Does Korean Drug Co Ltd allow for Work Councils/Collective Agreements to be formed?

Does Korean Drug Co Ltd report the number of strikes or work related stoppages?

Does Korean Drug Co Ltd have an accelerator or VC vehicle to help deliver innovation?

Does Korean Drug Co Ltd have a chief innovation officer?

Does Korean Drug Co Ltd disclose the ratio of CEO total compensation relative to average employee compensation ?

Does Korean Drug Co Ltd disclose its gender pay gap?

Subscription required

Does Korean Drug Co Ltd disclose its ethnicity pay gap?

Does Korean Drug Co Ltd disclose the number of employees in R&D functions?

Does Korean Drug Co Ltd engage in animal testing?

Subscription required

Does Korean Drug Co Ltd engage in stem cell research?

Does Korean Drug Co Ltd have a commitment to a living wage?

Does Korean Drug Co Ltd disclose the vesting schedule of its equity compensation plan?

Is executive remuneration linked to climate performance?

Does Korean Drug Co Ltd offer flexible work?

Does Korean Drug Co Ltd disclose employee diversity metrics?

Does Korean Drug Co Ltd disclose employee gender diversity metrics?

Does Korean Drug Co Ltd disclose the pay ratio of women to men?

Does Korean Drug Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

Does Korean Drug Co Ltd disclose information on fatalities and accidents in the workplace

Subscription required

Does Korean Drug Co Ltd report instances of occupational ill health, injury and fatality?

Does Korean Drug Co Ltd disclose reportable workplace incidents?

Does Korean Drug Co Ltd disclose the number of employees, new hires and turnover metrics?

Subscription required

Does Korean Drug Co Ltd disclose parental leave metrics?

Does Korean Drug Co Ltd disclose employee training metrics?

Does Korean Drug Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

Does Korean Drug Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

Does Korean Drug Co Ltd disclose the number of customer privacy complaints?

Subscription required

Does Korean Drug Co Ltd disclose incidents of discrimination?

Does Korean Drug Co Ltd disclose incidents relating human rights, child labour and forced labour?

Does Korean Drug Co Ltd disclose incidents of corruption?

Subscription required

Does Korean Drug Co Ltd disclose the number of incidents involving the rights of indigenous peoples?

Does Korean Drug Co Ltd disclose incidents of non-compliance in relation to product and service information/labelling or marketing communications?

Subscription required

Did Korean Drug Co Ltd have a product recall in the last two years?

Does Korean Drug Co Ltd support suppliers with sustainability related research and development?

Does Korean Drug Co Ltd have careers partnerships with academic institutions?

Is Korean Drug Co Ltd involved in embryonic stem cell research?

Does Korean Drug Co Ltd avoid gender bias in its hiring?

Does Korean Drug Co Ltd disclose the number of hours and/or employees/security personnel trained on human rights policies or procedures?

Have a different question?

View pricing detailsSign up for free

Potential Risks for Korean Drug Co Ltd
These potential risks are based on the size, segment and geographies of the company.

Do you want to create your own ESG Scorecard that you can share with your team members?

1/10 free views/searches used

You're viewing a Free Open ESG Rating.
To access the most comprehensive ESG data experience, Sign up to SEVVA Platform.

Korean Drug Co., Ltd. develops, manufactures, and sales medicines for treating various diseases in South Korea. The company provides medicines for treating central nervous system and cold. It also offers prescription drugs, including antibiotic, antifungal, digestive system medicine, circulatory system, psychiatric, and central nervous system drugs; drugs for the urinary system, and skinantiviral. In addition, the company provides over the counter drugs comprising drugs for liver disease and cold medicine, as well as offers health functional foods. Further, the company offers xprugel, a transparent gel for disinfection of hands and skin. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea.